You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ACETAMINOPHEN; BUTALBITAL; CAFFEINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00573170 ↗ TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults Completed GlaxoSmithKline Phase 3 2008-02-01 Study TRX109011/TRX109013, A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) versus Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when administered during the Moderate-Severe Pain Phase of the Migraine (Studies 1 and 2 of 2)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Condition Name

Condition Name for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Intervention Trials
Migraine Disorders 1
Migraine, Acute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Intervention Trials
Migraine Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Trials by Country

Trials by Country for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Location Trials
United States 33
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Location Trials
Kentucky 1
Indiana 1
Illinois 1
Georgia 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Clinical Trial Phase

Clinical Trial Phase for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Sponsor Name

Sponsor Name for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Sponsor Trials
GlaxoSmithKline 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Sponsor Trials
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.